Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients - Test2 - elhamkhani - TriplyDB

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

http://www.wikidata.org/entity/Q24551181

about

Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat Cystic fibrosis therapy: a community ecology perspective Mucociliary clearance: pathophysiological aspects Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche Cationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infections The small RNA PhrS stimulates synthesis of the Pseudomonas aeruginosa quinolone signal Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis Airway hydration and COPD Bacterial community morphogenesis is intimately linked to the intracellular redox state Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa Global regulator Anr represses PlcH phospholipase activity in Pseudomonas aeruginosa when oxygen is limiting The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung.ChIP-Seq and RNA-Seq reveal an AmrZ-mediated mechanism for cyclic di-GMP synthesis and biofilm development by Pseudomonas aeruginosa Pseudomonas aeruginosa PA1006, which plays a role in molybdenum homeostasis, is required for nitrate utilization, biofilm formation, and virulence The Pseudomonas aeruginosa ribbon-helix-helix DNA-binding protein AlgZ (AmrZ) controls twitching motility and biogenesis of type IV pili Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions Local and global regulators linking anaerobiosis to cupA fimbrial gene expression in Pseudomonas aeruginosa Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis Anr and its activation by PlcH activity in Pseudomonas aeruginosa host colonization and virulence The CgrA and CgrC proteins form a complex that positively regulates cupA fimbrial gene expression in Pseudomonas aeruginosa Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons Oxygen levels rapidly modulate Pseudomonas aeruginosa social behaviours via substrate limitation of PqsH The OpdQ porin of Pseudomonas aeruginosa is regulated by environmental signals associated with cystic fibrosis including nitrate-induced regulation involving the NarXL two-component system Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa Pyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected]Morphological optimization for access to dual oxidants in biofilms The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa A Putative ABC Transporter Permease Is Necessary for Resistance to Acidified Nitrite and EDTA in Pseudomonas aeruginosa under Aerobic and Anaerobic Planktonic and Biofilm Conditions.Pseudomonas aeruginosa Alginate Overproduction Promotes Coexistence with Staphylococcus aureus in a Model of Cystic Fibrosis Respiratory Infection Redox-Active Sensing by Bacterial DksA Transcription Factors Is Determined by Cysteine and Zinc Content Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection

P2860

Q21132701-F82F83B8-F298-4E83-8C74-BFE47EF25648 Q21144908-7C64DB16-8DDC-4814-90F6-A30C992D6EB7 Q21559420-5FA07141-BCA7-4739-8D19-B9CE2C68D286 Q24675645-40690AF0-0174-466A-9C74-B1F67F9E2E53 Q24678466-51F3F627-E18D-4539-A3EF-03E8309FD4C3 Q24802489-8854C881-4C45-4CB1-BF66-6E73CE792ABC Q26771468-64C34D39-DCFE-4F7B-8B7C-5FD0422CA5DF Q27015964-F3E7D8A4-0BD6-4E93-A004-44EA16C2AE21 Q27022272-EAF00DAF-DEC1-4352-B806-5582730B4171 Q27317084-0ED5622D-96B7-4D48-A278-4A2CE9EBC5D5 Q27327282-0CAA1AFD-610F-4628-8291-1458B817329F Q28058215-E6D4AE56-F18F-452C-9FE3-7D7787608E6C Q28071357-D13F8DE2-C8EB-42C1-AF70-16324A985D9C Q28073996-7B9096D4-C8F8-4EA6-A196-8905E749C4CA Q28082617-1A1907FB-1E10-4467-8956-40137AA44E77 Q28282739-ADC3CC42-0B2D-49E3-82F3-CE9744C660B6 Q28492485-4BA88FB2-5B7C-450F-90AF-3D8CE1DCC58F Q28492516-30E43B18-148D-4ECE-9261-C0861DB14C69 Q28492530-E6F8E208-F20B-426D-A123-4682B8B70CF9 Q28492571-FB4BFB15-7833-4F60-95F4-68BE51678DA2 Q28492614-9B9ED310-3338-47C1-92C2-0DDBB9172595 Q28492694-46D458AC-0C66-4973-9CB6-96302E7F1F2A Q28492742-AA3C7593-1378-4151-9A74-FB020FE36528 Q28492782-67341327-5C44-47D6-9EFA-73F9FB211353 Q28492813-315673A3-90CD-4401-96B5-369F6A2CE2E8 Q28492843-85239FB8-DBAE-454A-B005-E474E8B82166 Q28492858-E45F1335-F344-415B-84F0-9D17136173CF Q28492896-CD6E8FAB-7224-47B7-B73D-147286FF0B8D Q28493012-13D274CC-3F12-4607-BAF1-6B265F6F349F Q28493027-D2D1AE25-33F9-47BA-A5A1-E78AB88779A6 Q28493218-6287A457-7999-4B9C-8359-89C1F8776AD0 Q28541355-215FB294-42C9-4EE2-9909-590C7FB5F500 Q28543599-F1D6E1E4-6D19-460F-93DB-C7FC4F7E4EF6 Q28660646-E064A720-E6C5-41F5-BAC2-3F703662B55E Q29346795-0D4FF4C0-1B20-4DA7-8B1A-12085773CFBF Q29346826-966DCAD7-FE31-45C0-9AAB-E0C656C43467 Q30252902-639B6F35-1848-44F5-A25D-6D55D5F74EEF Q30387100-F7DECA9E-226E-47AE-9940-A6E5F01D6904 Q30426714-30C4F9EF-398B-431F-A119-069DF45B973F Q30432839-9DB09596-9529-4783-89B2-AC0639A27A5C

P2860

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

http://www.wikidata.org/entity/Q24551181

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@ast

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@en

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@nl

type

label

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@ast

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@en

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@nl

prefLabel

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@ast

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@en

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@nl

P1433

Q24551181-589E1188-304A-4D7D-B6D8-A6FE344BE071

P1476

Q24551181-2A815485-7DE7-4622-AF38-83E7CB41D72D

P2093

Q24551181-06BE2396-020F-47B2-9FB7-79368E044DCE

Q24551181-08960AF6-F2A1-4B1A-829E-06779847F3A1

Q24551181-09D81C99-8E63-4712-8789-E490F3D4259A

Q24551181-1E135902-CFA1-483E-B457-6CCD6A934AEC

Q24551181-44844F90-1EF7-423C-9074-35A749064127

Q24551181-59061277-ABBD-4207-85C1-2D38CB7C51A0

Q24551181-7B9F8E51-880C-4E8F-9E73-39B0336E16C2

Q24551181-7BA75B5C-D222-48DF-8956-A88788AE0B29

Q24551181-8ED21BEC-0EF6-4D32-944E-9019327E9053

Q24551181-AAA53E55-EE15-44CA-8700-2B6BBC7428A3

P2860

Q24551181-0A5063D2-58C0-4737-930D-DC049660FC80

Q24551181-1D9AE03F-E8D1-4E06-8335-DC9BC5636A00

Q24551181-2DFFCD8B-E68D-4562-B4D8-512826732B6A

Q24551181-39E8BD5A-6026-4D58-AA8E-C31C31E012B8

Q24551181-3BAE200D-9D3B-433E-ABAF-A019708D827E

Q24551181-3FFD87C9-9FAA-4FF8-90E7-95BC217C3DBF

Q24551181-4DF5859F-B025-42F3-9E6C-2626BB24D491

Q24551181-4E51CEF0-FC88-402C-A53F-444BB6C6B960

Q24551181-4EECE958-992E-47E5-BCDF-B7707EB20C52

Q24551181-50926A88-F26A-41A5-B0B4-F96FEC05793F

P304

Q24551181-B5999A42-A383-4B10-BE9C-6F1F7C2EEAB4

P31

Q24551181-AFA6CF02-0F82-4291-90E1-542E3FC1907A

P3181

Q24551181-8CAC8D80-A2A2-47E8-8AB7-ED5A956E0F89

P356

Q24551181-303A7E97-FFB0-47EA-90B8-7A771CED2D63

Q24551181-58D8F7E8-95E0-4B38-9EB0-7957E3F5D17E

P407

Q24551181-38519843-78C6-4105-9C1F-E49794D55F21

P433

Q24551181-E1C8A161-76A4-4B81-9281-2A82883EE905

P478

Q24551181-8D9545A6-B02A-488D-9ED1-611E7E234786

P577

Q24551181-AC098B02-BE29-4EBC-A460-44330BCE8406

P698

Q24551181-BF301B2A-01B9-4F90-BC89-99101D9BC669

P921

Q24551181-68C2E4DB-64DC-4F28-9E42-A74A7F77C727

P932

Q24551181-6DBAB4E1-21A4-4C1E-A304-482B34727555

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Effects of reduced mucus oxyge ...... ns of cystic fibrosis patients

@en

P2093

Aynur Cekici

http://www.w3.org/2001/XMLSchema#string

Dieter Worlitzsch

http://www.w3.org/2001/XMLSchema#string

Gabriel Bellon

http://www.w3.org/2001/XMLSchema#string

Gerd Döring

http://www.w3.org/2001/XMLSchema#string

James R Yankaskas

http://www.w3.org/2001/XMLSchema#string

Jürgen Berger

http://www.w3.org/2001/XMLSchema#string

Keith C Meyer

http://www.w3.org/2001/XMLSchema#string

Konrad Botzenhart

http://www.w3.org/2001/XMLSchema#string

Martina Ulrich

http://www.w3.org/2001/XMLSchema#string

Peter Birrer

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen

Chromosomal genetics of Pseudomonas

Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation.

Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis

Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells

Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis.

Mucus clearance as a primary innate defense mechanism for mammalian airways.

Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

P304

317-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

627532

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI0213870

http://www.w3.org/2001/XMLSchema#string

10.1172/JCI13870

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11827991

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

150856

http://www.w3.org/2001/XMLSchema#string